Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent C Tam

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
BMC Medical Education|August 29, 2020
Oncology education for family medicine residents: a national needs assessment surveySteven M Yip, Daniel E Meyers, Jeff Sisler, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2002
Genomewide identification of proteins secreted by the Hrp type III protein secretion system of Pseudomonas syringae pv. tomato DC3000Tanja Petnicki-Ocwieja, David J Schneider, Vincent C Tam, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2005
Genomic characterization of non-O1, non-O139 Vibrio cholerae reveals genes for a type III secretion systemMichelle Dziejman, Davide Serruto, Vincent C Tam, et al.
British Journal of Cancer|July 22, 2022
Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancerMark K Doherty, Vincent C Tam, Mairéad G McNamara, et al.
Cancer Medicine|June 13, 2020
Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter DatabaseMohammed A Alghamdi, Carla P Amaro, Richard Lee-Ying, et al.
Cancers|August 29, 2024
Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding ComplicationsCha Len Lee, Mark Freeman, Kelly W Burak, et al.
Cancer Medicine|May 17, 2018
Prognosis of patients with hepatocellular carcinoma treated with sorafenib: a comparison of five models in a large Canadian databaseHaider H Samawi, Hao-Wen Sim, Kelvin K Chan, et al.
Cancer Treatment Reviews|March 16, 2023
Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in CanadaJason K Wong, Howard J Lim, Vincent C Tam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2020
Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular CarcinomaRobin Kate Kelley, Tim Meyer, Lorenza Rimassa, et al.
Scientific Reports|August 5, 2014
Structural analysis of H1N1 and H7N9 influenza A virus PA in the absence of PB1Spencer O Moen, Jan Abendroth, James W Fairman, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
BMC Medical Education|August 29, 2020
Oncology education for family medicine residents: a national needs assessment surveySteven M Yip, Daniel E Meyers, Jeff Sisler, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2002
Genomewide identification of proteins secreted by the Hrp type III protein secretion system of Pseudomonas syringae pv. tomato DC3000Tanja Petnicki-Ocwieja, David J Schneider, Vincent C Tam, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2005
Genomic characterization of non-O1, non-O139 Vibrio cholerae reveals genes for a type III secretion systemMichelle Dziejman, Davide Serruto, Vincent C Tam, et al.
British Journal of Cancer|July 22, 2022
Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancerMark K Doherty, Vincent C Tam, Mairéad G McNamara, et al.
Cancer Medicine|June 13, 2020
Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter DatabaseMohammed A Alghamdi, Carla P Amaro, Richard Lee-Ying, et al.
Cancers|August 29, 2024
Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding ComplicationsCha Len Lee, Mark Freeman, Kelly W Burak, et al.
Cancer Medicine|May 17, 2018
Prognosis of patients with hepatocellular carcinoma treated with sorafenib: a comparison of five models in a large Canadian databaseHaider H Samawi, Hao-Wen Sim, Kelvin K Chan, et al.
Cancer Treatment Reviews|March 16, 2023
Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in CanadaJason K Wong, Howard J Lim, Vincent C Tam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2020
Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular CarcinomaRobin Kate Kelley, Tim Meyer, Lorenza Rimassa, et al.
Scientific Reports|August 5, 2014
Structural analysis of H1N1 and H7N9 influenza A virus PA in the absence of PB1Spencer O Moen, Jan Abendroth, James W Fairman, et al.
Pageof 5